View in EDS

Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.

Saved in:
Bibliographic Details
Title: Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
Authors: Trefond, Ludovic1 (AUTHOR) ltrefond@chu-clermontferrand.fr, Drumez, Elodie2 (AUTHOR), Andre, Marc1 (AUTHOR), Costedoat-Chalumeau, Nathalie3 (AUTHOR), Seror, Raphaèle4 (AUTHOR), Devaux, Mathilde5 (AUTHOR), Dernis, Emmanuelle6 (AUTHOR), Dieudonné, Yannick7 (AUTHOR), El Mahou, Soumaya8 (AUTHOR), Lanteri, Aurelia9 (AUTHOR), Melki, Isabelle10 (AUTHOR), Queyrel, Viviane11 (AUTHOR), Roumier, Mathilde12 (AUTHOR), Schmidt, Jean13 (AUTHOR), Barnetche, Thomas14 (AUTHOR), Thomas, Thierry15 (AUTHOR), Cacoub, Patrice16,17,18,19 (AUTHOR), Belot, Alexandre20 (AUTHOR), Aumaitre, Olivier1 (AUTHOR), Richez, Christophe14 (AUTHOR)
Source: Joint Bone Spine. Dec2021, Vol. 88 Issue 6, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:1297319X
DOI:10.1016/j.jbspin.2021.105226